Mertens, B.; Elkayal, O.; Dreesen, E.; Wauters, J.; Meersseman, P.; Debaveye, Y.; Degezelle, K.; Vermeersch, P.; Gijsen, M.; Spriet, I.
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics 2023, 12, 1085.
https://doi.org/10.3390/antibiotics12071085
AMA Style
Mertens B, Elkayal O, Dreesen E, Wauters J, Meersseman P, Debaveye Y, Degezelle K, Vermeersch P, Gijsen M, Spriet I.
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics. 2023; 12(7):1085.
https://doi.org/10.3390/antibiotics12071085
Chicago/Turabian Style
Mertens, Beatrijs, Omar Elkayal, Erwin Dreesen, Joost Wauters, Philippe Meersseman, Yves Debaveye, Karlien Degezelle, Pieter Vermeersch, Matthias Gijsen, and Isabel Spriet.
2023. "Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review" Antibiotics 12, no. 7: 1085.
https://doi.org/10.3390/antibiotics12071085
APA Style
Mertens, B., Elkayal, O., Dreesen, E., Wauters, J., Meersseman, P., Debaveye, Y., Degezelle, K., Vermeersch, P., Gijsen, M., & Spriet, I.
(2023). Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature Review. Antibiotics, 12(7), 1085.
https://doi.org/10.3390/antibiotics12071085